Compile Data Set for Download or QSAR
Report error Found 3391 for UniProtKB: P25090
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608846(CHEMBL5271637)
Affinity DataEC50:  0.0200nMAssay Description:Agonist activity at FPR2 (unknown origin) assessed as increase in calcium fluxMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559837(CHEMBL4776349)
Affinity DataEC50:  0.0500nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450307(US10676431, Example 70 | US11117861, Example 70)
Affinity DataEC50:  0.0770nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450307(US10676431, Example 70 | US11117861, Example 70)
Affinity DataEC50:  0.0770nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559838(CHEMBL4790836)
Affinity DataEC50:  0.0780nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559814(CHEMBL4743917)
Affinity DataEC50:  0.0850nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559836(CHEMBL4755590)
Affinity DataEC50:  0.0870nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM620556(US20230303513, Example 4)
Affinity DataEC50:  0.100nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50520819(CHEMBL4440913)
Affinity DataIC50: 0.100nMAssay Description:Agonist activity at ALX/FPR2 in human THP1 cells harboring NF-kB-Luc assessed as inhibition of LPS-induced NFkB signalling activation by measuring re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/23/2021
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM632092(US20230348426, Example 362 | US20230348426, Exampl...)
Affinity DataEC50:  0.100nMAssay Description: A mixture of forskolin (5 M final for FPR2 or 10 M final for FPR1) and IBMX (200 M final) were added to 384-well Proxiplates (Perkin-Elmer) pre-dott...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559811(CHEMBL4784400)
Affinity DataEC50:  0.110nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559830(CHEMBL4758920)
Affinity DataEC50:  0.110nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454204(US10717708, Example 188 | US11186544, Example 188 ...)
Affinity DataEC50:  0.130nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608856(CHEMBL5288361)
Affinity DataEC50:  0.130nMAssay Description:Agonist activity at human FPR2 expressed in HEK293 cells assessed as increase in calcium flux incubated for 45 mins by Fluo-4 AM dye based fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454204(US10717708, Example 188 | US11186544, Example 188 ...)
Affinity DataEC50:  0.130nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454204(US10717708, Example 188 | US11186544, Example 188 ...)
Affinity DataEC50:  0.130nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454192(US10717708, Example 86 | US11186544, Example 86 | ...)
Affinity DataEC50:  0.140nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559821(CHEMBL4781596)
Affinity DataEC50:  0.140nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454192(US10717708, Example 86 | US11186544, Example 86 | ...)
Affinity DataEC50:  0.140nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454192(US10717708, Example 86 | US11186544, Example 86 | ...)
Affinity DataEC50:  0.140nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454192(US10717708, Example 86 | US11186544, Example 86 | ...)
Affinity DataEC50:  0.140nMAssay Description:Agonist activity at human FPR2 expressed in CHO cells assessed as cAMP level incubated for 1.5 hr by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559820(CHEMBL4744835)
Affinity DataEC50:  0.150nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559835(CHEMBL4762030)
Affinity DataEC50:  0.160nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608851(CHEMBL5281870)
Affinity DataEC50:  0.170nMAssay Description:Agonist activity at human FPR2 expressed in HEK293 cells assessed as increase in calcium flux incubated for 45 mins by Fluo-4 AM dye based fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM517780(US11124494, Example 18)
Affinity DataEC50:  0.170nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM526327(US11186544, Example 277)
Affinity DataEC50:  0.170nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559810(CHEMBL4744094)
Affinity DataEC50:  0.180nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559810(CHEMBL4744094)
Affinity DataEC50:  0.180nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM497407(US11008301, Example 77)
Affinity DataEC50:  0.180nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/14/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559831(CHEMBL4761554)
Affinity DataEC50:  0.190nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM620557(US20230303513, Example 16 | US20230303513, Example...)
Affinity DataEC50:  0.200nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays were used to measure the activity of the compounds in this patent. FPR2 and FPR1 Cyclic Ad...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM632258(US20230348426, Example 528)
Affinity DataEC50:  0.200nMAssay Description: A mixture of forskolin (5 M final for FPR2 or 10 M final for FPR1) and IBMX (200 M final) were added to 384-well Proxiplates (Perkin-Elmer) pre-dott...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM517783(US11124494, Example 42)
Affinity DataEC50:  0.210nMAssay Description:Agonist activity at human FPR2 expressed in CHO cells assessed as cAMP level incubated for 1.5 hr by HTRF assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM517783(US11124494, Example 42)
Affinity DataEC50:  0.210nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450267(US10676431, Example 30 | US11117861, Example 30)
Affinity DataEC50:  0.220nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450267(US10676431, Example 30 | US11117861, Example 30)
Affinity DataEC50:  0.220nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50563096(CHEMBL4794375)
Affinity DataEC50:  0.25nMAssay Description:Agonist activity at FPR2 (unknown origin) assessed as increase in calcium fluxMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608849(CHEMBL5287715)
Affinity DataEC50:  0.25nMAssay Description:Agonist activity at human FPR2 expressed in HEK293 cells assessed as increase in calcium flux incubated for 45 mins by Fluo-4 AM dye based fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50563096(CHEMBL4794375)
Affinity DataEC50:  0.25nMAssay Description:Agonist activity at FPR2 (unknown origin) by calcium mobilization assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM350655(diethyl ({[(2S)-2-{[(4- bromophenyl)carbamoyl]amin...)
Affinity DataEC50:  0.270nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608855(CHEMBL5273168)
Affinity DataEC50:  0.270nMAssay Description:Agonist activity at human FPR2 expressed in HEK293 cells assessed as increase in calcium flux incubated for 45 mins by Fluo-4 AM dye based fluorescen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450349(US10676431, Example 112 | US11117861, Example 112)
Affinity DataEC50:  0.270nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450349(US10676431, Example 112 | US11117861, Example 112)
Affinity DataEC50:  0.270nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/26/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM350655(diethyl ({[(2S)-2-{[(4- bromophenyl)carbamoyl]amin...)
Affinity DataEC50:  0.270nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454206(US10717708, Example 199 | US11186544, Example 199 ...)
Affinity DataEC50:  0.280nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/16/2023
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454206(US10717708, Example 199 | US11186544, Example 199 ...)
Affinity DataEC50:  0.280nMAssay Description:FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM454206(US10717708, Example 199 | US11186544, Example 199 ...)
Affinity DataEC50:  0.280nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/9/2022
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50559840(CHEMBL4760897)
Affinity DataEC50:  0.290nMAssay Description:Agonist activity at human FPR2 expressed in HEK 293 cells co-expressing Galpha15 measured every 1.5 sec for 80 sec by Fluo-4 NW staining based scanni...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/28/2022
Entry Details Article
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM50608847(CHEMBL5275581)
Affinity DataEC50:  0.290nMAssay Description:Agonist activity at FPR2 (unknown origin) assessed as increase in calcium fluxMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/20/2024
Entry Details
PubMed
TargetN-formyl peptide receptor 2(Human)
Queen Mary University of London

Curated by ChEMBL
LigandPNGBDBM450358(US10676431, Example 121 | US10676431, Example 122 ...)
Affinity DataEC50:  0.300nMAssay Description:A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/10/2021
Entry Details
US Patent

Displayed 1 to 50 (of 3391 total ) | Next | Last >>
Jump to: